Presence of circulating tumour DNA in surgically resected renal cell carcinoma is associated with advanced disease and poor patient prognosis
Year: 2019
Type: article
Study design: Observational Study
Source: Annals of Oncology
Authors: A. Correa, D.C. Connolly, M. Balcioglu, H.-T. Wu, S. Dashner, S. Shchegrova, E. Kalashnikova, H. Pawar, R.G. Uzzo, Y. Gong, D. Kister, M. Collins, M. Donovan, R. Winters, A. Aleshin, H. Sethi, R. Salari, M. Louie, B. Zimmermann, P. Abbosh
Institutions: Fox Chase Cancer Center, Natera (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Celgene, Taiho Pharmaceutical, Exelixis, Incyte, MacroGenics, Daiichi-Sankyo, Dainippon Sumitomo Pharma, Eisai, Astellas Pharma, Teijin Pharma, Yakult Honsha, Ono Pharmaceutical, Genentech, Novartis Pharma, Chugai Pharmaceutical, Eli Lilly Japan, Daiichi Sankyo Company, Daiichi Sankyo Europe
OpenAlex ID: W2978515505